Register to receive a free Interventional Cardiology Devices Market Report Suite for U.S. 2023-2029 synopsis and brochure
Register to receive a free Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and treatment options. Devices for the diagnosis and treatment of CAD can be of high volume and low cost or of a relatively low volume and high cost. The U.S. interventional cardiology market, worth over $3.9 billion, is currently being influenced and driven by interventional and diagnostic procedures, as well as demographic factors and technological innovation.
Stabilized Angiography and PCI Procedures: Driving Market Growth
Growth of the interventional cardiology market is highly correlated to annual fluctuations in two procedure types — diagnostic angiography and percutaneous coronary intervention (PCI). These procedures have recently experienced a turnaround, from decline to growth, over the past few years.
Although relatively new computerized diagnostic techniques, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), provide a more detailed visual assessment of coronary arteries, angiography remains the gold standard for diagnostic coronary procedures and will continue to be used for the detection of CAD for the foreseeable future. As a result, associated device markets, such as diagnostic catheters and diagnostic guidewires, will continue to grow.
PCIs, also known as coronary angioplasties, are one of the main treatment options for CAD and typically involve the use of a coronary balloon catheter and a coronary stent. With the volume of PCI procedures in the United States estimated at more than 1,000,000 per year and rising, there will be positive growth in many associated device markets, such as interventional catheters, interventional guidewires and various other devices used per procedure. This is good news, considering that PCI procedure volumes, as well as coronary balloon and stent sales, have experienced substantial declines for several years following multiple clinical studies that presented evidence of over-stenting. However, procedure volume has recently stabilized, and growth is expected to continue, due to the emergence of a new area of opportunity — complex PCI cases.
Additional Market Drivers
Demographic Factors
As the population ages and grows, demographics continue to play an important role in the market. According to the American Heart Association, about 18.2 million adults aged 20 and older have cardiac artery disease (CAD), which represents about 6.7% of all American adults. Due to the increased prevalence of cardiovascular disease with age, procedure numbers and potential patients are both on the rise.
New Technological Developments
Cardiovascular imaging techniques, including computerized tomography (CT), magnetic resonance imaging (MRI), intravascular ultrasound (IVUS) and optical coherence tomography (OCT), have become increasingly popular, increasing the likelihood of detecting lesions that require stenting. The next generation of drug-eluting stents will have improved stent construction and thinner drug coatings, which will increase their success rate and broaden the range of lesions they can treat.
For More Information
More research on angioplasty and PCI procedure volumes can be found in the full report suite, titled U.S. Market Report Suite for Interventional Cardiology Devices 2023 – MedSuite, which provides a comprehensive report on units sold, market values, average selling prices, procedure volumes and forecasts, as well as detailed competitive market shares and analysis of all major competitors.
This suite of reports include segments for coronary stents, coronary balloon catheters, balloon-inflation devices, interventional coronary catheters, interventional coronary guidewires, coronary embolic protection devices (EPD), coronary atherectomy and intravascular lithotripsy devices, coronary thrombectomy devices, coronary chronic total occlusion (CTO) systems, introducer sheaths, coronary vascular closure devices (VCD), diagnostic coronary catheters and guidewires, coronary intravascular ultrasound (IVUS), coronary optical coherence tomography (OCT) and hemostasis valves.
